The skin surface as antimicrobial barrier: Present concepts and future outlooks

Experimental Dermatology

Volumn 22, Issue 1, 2013, Pages 1-5

  Harder, Jürgen ^a   Schröder, Jens Michael ^a   Gläser, Regine ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Antimicrobial proteins; Cutaneous defense

Indexed keywords

ADENOSINE PHOSPHATE; ARYLDIALKYLPHOSPHATASE 2; BACTERIOCIN; BETA DEFENSIN 2; BETA DEFENSIN 3; CALGRANULIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CHEMOKINE RECEPTOR CCR6; DERMCIDIN; LACTOFERRIN; MEMBRANE COFACTOR PROTEIN; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; OLIGOSACCHARIDE; PROTEIN S 100; PSORIASIN; SULFITE; TOLL LIKE RECEPTOR;

ARTICLE; ATOPIC DERMATITIS; BACTERIAL COLONIZATION; BACTEROIDES THETAIOTAOMICRON; BIFIDOBACTERIUM LONGUM INFANTIS; BIOFILM; BREAST MILK; CELL INTERACTION; DIABETES MELLITUS; DISEASE SEVERITY; EPIDERMIS; GENE EXPRESSION; HUMAN; IMMUNOCOMPETENT CELL; KERATINOCYTE; MICROBIAL GROWTH; PROPIONIBACTERIUM ACNES; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; QUORUM SENSING; SKIN FLORA; SKIN PROTECTION; SKIN SURFACE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STRATUM CORNEUM; ULTRAVIOLET RADIATION; WOUND HEALING;

ANIMALS; ANTIBIOSIS; ANTIMICROBIAL CATIONIC PEPTIDES; BETA-DEFENSINS; HUMANS; IMMUNITY, INNATE; KERATINOCYTES; LEUKOCYTE L1 ANTIGEN COMPLEX; METAGENOME; PEPTIDES; RIBONUCLEASES; S100 PROTEINS; SKIN;

EID: 84871720233     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12046     Document Type: Article

References (82)

1. Augustin R, Fraune S, Franzenburg S et al. Adv Exp Med Biol 2012: 710: 71-81.
2. Bosch T C, Augustin R, Anton-Erxleben F et al. Dev Comp Immunol 2009: 33: 559-569.
3. Jung S, Dingley A J, Augustin R et al. J Biol Chem 2009: 284: 1896-1905.
4. Grice E A, Kong H H, Conlan S et al. Science 2009: 324: 1190-1192.
5. Grice E A, Segre J A. Nat Rev Microbiol 2011: 9: 244-253.
6. Baroni A, Buommino E, De Gregorio V et al. Clin Dermatol 2012: 30: 257-262.
7. Elias P M. J Invest Dermatol 2005: 125: 183-200.
8. Gläser R, Harder J, Lange H et al. Nat Immunol 2005: 6: 57-64.
9. Gebhardt C, Nemeth J, Angel P et al. Biochem Pharmacol 2006: 72: 1622-1631.
10. Harder J, Schröder J M. J Biol Chem 2002: 277: 46779-46784.
11. Park J H, Park G T, Cho I H et al. Exp Dermatol 2011: 20: 369-371.
12. Schittek B, Hipfel R, Sauer B et al. Nat Immunol 2001: 2: 1133-1137.
13. Antunes L C, Ferreira R B, Buckner M M et al. Microbiology 2010: 156: 2271-2282.
14. De Koning H D, Simon A, Zeeuwen P L et al. Microbes Infect 2012: 14: 881-893.
15. Abtin A, Eckhart L, Gläser R et al. J Invest Dermatol 2010: 130: 2423-2430.
16. Abtin A, Eckhart L, Mildner M et al. FASEB J 2008: 22: 2168-2176.
17. Harder J, Dressel S, Wittersheim M et al. J Invest Dermatol 2010: 130: 1355-1364.
18. Köten B, Simanski M, Gläser R et al. PLoS ONE 2009: 4: e6424.
19. Gerstel U, Czapp M, Bartels J et al. Cell Microbiol 2009: 11: 842-853.
20. Lai Y, Cogen A L, Radek K A et al. J Invest Dermatol 2010: 130: 2211-2221.
21. Menzies B E, Kenoyer A. Infect Immun 2006: 74: 6847-6854.
22. Sumikawa Y, Asada H, Hoshino K et al. Microbes Infect 2006: 8: 1513-1521.
23. Wanke I, Steffen H, Christ C et al. J Invest Dermatol 2011: 131: 382-390.
24. Voss E, Wehkamp J, Wehkamp K et al. J Biol Chem 2006: 281: 2005-2011.
25. Guilloteau K, Paris I, Pedretti N et al. J Immunol 2010: 184: 5263-5270.
26. Liang S C, Tan X Y, Luxenberg D P et al. J Exp Med 2006: 203: 2271-2279.
27. Liu A Y, Destoumieux D, Wong A V et al. J Invest Dermatol 2002: 118: 275-281.
28. Peric M, Koglin S, Kim S M et al. J Immunol 2008: 181: 8504-8512.
29. Wehkamp K, Schwichtenberg L, Schröder J M et al. J Invest Dermatol 2006: 126: 121-127.
30. Wolk K, Kunz S, Witte E et al. Immunity 2004: 21: 241-254.
31. Sorensen O E, Cowland J B, Theilgaard-Monch K et al. J Immunol 2003: 170: 5583-5589.
32. Sorensen O E, Thapa D R, Roupe K M et al. J Clin Invest 2006: 116: 1878-1885.
33. Dressel S, Harder J, Cordes J et al. Exp Dermatol 2010: 19: 628-632.
34. Gläser R, Navid F, Schuller W et al. J Allergy Clin Immunol 2009a: 123: 1117-1123.
35. Dombrowski Y, Schauber J. Exp Dermatol 2012: 21: 327-330.
36. Schauber J, Dorschner R A, Coda A B et al. J Clin Invest 2007: 117: 803-811.
37. Wang T T, Nestel F P, Bourdeau V et al. J Immunol 2004: 173: 2909-2912.
38. Kong H H, Segre J A. J Invest Dermatol 2012: 132: 933-939.
39. Kong H H, Oh J, Deming C et al. Genome Res 2012: 22: 850-859.
40. Grice E A, Snitkin E S, Yockey L J et al. Proc Natl Acad Sci USA 2010: 107: 14799-14804.
41. Gallo R L, Nakatsuji T. J Invest Dermatol 2011: 131: 1974-1980.
42. Hassan M, Kjos M, Nes I F et al. J Appl Microbiol 2012: 113: 723-736.
43. Bastos M C, Ceotto H, Coelho M L et al. Curr Pharm Biotechnol 2009: 10: 38-61.
44. Varella Coelho M L, Santos Nascimento J D, Fagundes P C et al. Res Microbiol 2007: 158: 625-630.
45. Iwase T, Uehara Y, Shinji H et al. Nature 2010: 465: 346-349.
46. Cogen A L, Yamasaki K, Sanchez K M et al. J Invest Dermatol 2010: 130: 192-200.
47. Holland D B, Bojar R A, Farrar M D et al. FEMS Microbiol Lett 2009: 290: 149-155.
48. Lai Y, Di Nardo A, Nakatsuji T et al. Nat Med 2009: 15: 1377-1382.
49. Fraune S, Bosch T C. Proc Natl Acad Sci USA 2007: 104: 13146-13151.
50. Fraune S, Augustin R, Anton-Erxleben F et al. Proc Natl Acad Sci USA 2010: 107: 18067-18072.
51. Salzman N H, Hung K, Haribhai D et al. Nat Immunol 2010: 11: 76-83.
52. Gallo R L, Hooper L V. Nat Rev Immunol 2012: 12: 503-516.
53. Bevins C L, Salzman N H. Cell Mol Life Sci 2011: 68: 3675-3685.
54. Bry L, Falk P G, Midtvedt T et al. Science 1996: 273: 1380-1383.
55. Monod M. Mycopathologia 2008: 166: 285-294.
56. Kehl-Fie T E, Chitayat S, Hood M I et al. Cell Host Microbe 2011: 10: 158-164.
57. Goetz D H, Holmes M A, Borregaard N et al. Mol Cell 2002: 10: 1033-1043.
58. Koprivnjak T, Peschel A. Cell Mol Life Sci 2011: 68: 2243-2254.
59. Meyer-Hoffert U. Arch Immunol Ther Exp (Warsz) 2009: 57: 345-354.
60. Okada N, Liszewski M K, Atkinson J P et al. Proc Natl Acad Sci USA 1995: 92: 2489-2493.
61. Timar K K, Pasch M C, Van Den Bosch N H et al. Mol Immunol 2006: 43: 317-325.
62. Simanski M, Babucke S, Eberl L et al. J Invest Dermatol 2012: 132: 2296-2299.
63. Lai Y, Villaruz A E, Li M et al. Mol Microbiol 2007: 63: 497-506.
64. Yao Y, Vuong C, Kocianova S et al. J Infect Dis 2006: 193: 841-848.
65. Voegeli D. J Wound Ostomy Continence Nurs 2008: 35: 84-90.
66. Harder J, Schröder J M. J Leukoc Biol 2005: 77: 476-486.
67. Henseler T, Christophers E. J Am Acad Dermatol 1995: 32: 982-986.
68. Gambichler T, Skrygan M, Tomi N S et al. Int Arch Allergy Immunol 2008: 147: 17-24.
69. Hollox E J, Huffmeier U, Zeeuwen P L et al. Nat Genet 2008: 40: 23-25.
70. Jansen P A, Rodijk-Olthuis D, Hollox E J et al. PLoS ONE 2009: 4: e4725.
71. Yang D, Chertov O, Bykovskaia S N et al. Science 1999: 286: 525-528.
72. Lande R, Gregorio J, Facchinetti V et al. Nature 2007: 449: 564-569.
73. Morizane S, Yamasaki K, Muhleisen B et al. J Invest Dermatol 2012: 132: 135-143.
74. Dombrowski Y, Peric M, Koglin S et al. Sci Transl Med 2011: 3: 82ra38.
75. Ong P Y, Ohtake T, Brandt C et al. N Engl J Med 2002: 347: 1151-1160.
76. Kisich K O, Howell M D, Boguniewicz M et al. J Invest Dermatol 2007: 127: 2368-2380.
77. Simanski M, Dressel S, Gläser R et al. J Invest Dermatol 2010: 130: 2836-2838.
78. Zanger P, Holzer J, Schleucher R et al. Infect Immun 2010: 78: 3112-3117.
79. Zanger P, Holzer J, Schleucher R et al. J Infect Dis 2009: 200: 1907-1915.
80. Gläser R, Meyer-Hoffert U, Harder J et al. J Invest Dermatol 2009b: 129: 641-649.
81. Ballardini N, Johansson C, Lilja G et al. Br J Dermatol 2009: 161: 40-47.
82. Peschel A, Sahl H G. Nat Rev Microbiol 2006: 4: 529-536.